Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 6, 2005
Melanin-concentrating hormone-1 receptor modulates neuroendocrine, behavioral, and corticolimbic neurochemical stress responses in mice
Daniel G Smith, Richard J Davis, Linda Rorick-Kehn, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 8, 2006
Angiotensin-II is a putative neurotransmitter in lactate-induced panic-like responses in rats with disruption of GABAergic inhibition in the dorsomedial hypothalamus
Anantha Shekhar, Philip L Johnson, Tammy J Sajdyk, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 29, 2013
LLY-2707, a novel nonsteroidal glucocorticoid antagonist that reduces atypical antipsychotic-associated weight gain in rats
Dana K Sindelar, Mathew W Carson, Michelle Morin, et al.
The European Journal of Neuroscience
|
September 30, 2005
The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors
Bouchaïb El Bahh, Silvia Balosso, Trevor Hamilton, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 3, 2009
Preclinical evaluation of melanin-concentrating hormone receptor 1 antagonism for the treatment of obesity and depression
Donald R Gehlert, Kurt Rasmussen, Janice Shaw, et al.
European Journal of Pharmacology
|
March 1, 2005
Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor
Donald R Gehlert, Anantha Shekhar, S Michelle Morin, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
January 25, 2008
Neuropeptide Y in the amygdala induces long-term resilience to stress-induced reductions in social responses but not hypothalamic-adrenal-pituitary axis activity or hyperthermia
Tammy J Sajdyk, Philip L Johnson, Randy J Leitermann, et al.
European Journal of Pharmacology
|
December 9, 2003
Na+-dependent high affinity binding of [3H]LY515300, a 3,4-dimethyl-4-(3-hydroxyphenyl)piperidine opioid receptor inverse agonist
Michael A Statnick, Todd M Suter, Susan L Gackenheimer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 15, 2002
Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder
Frank P Bymaster, Jason S Katner, David L Nelson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 9, 2007
3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethyl-imidazo[1,2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism
Donald R Gehlert, Andrea Cippitelli, Annika Thorsell, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 6, 2005
Melanin-concentrating hormone-1 receptor modulates neuroendocrine, behavioral, and corticolimbic neurochemical stress responses in mice
Daniel G Smith, Richard J Davis, Linda Rorick-Kehn, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 8, 2006
Angiotensin-II is a putative neurotransmitter in lactate-induced panic-like responses in rats with disruption of GABAergic inhibition in the dorsomedial hypothalamus
Anantha Shekhar, Philip L Johnson, Tammy J Sajdyk, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 29, 2013
LLY-2707, a novel nonsteroidal glucocorticoid antagonist that reduces atypical antipsychotic-associated weight gain in rats
Dana K Sindelar, Mathew W Carson, Michelle Morin, et al.
The European Journal of Neuroscience
|
September 30, 2005
The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors
Bouchaïb El Bahh, Silvia Balosso, Trevor Hamilton, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 3, 2009
Preclinical evaluation of melanin-concentrating hormone receptor 1 antagonism for the treatment of obesity and depression
Donald R Gehlert, Kurt Rasmussen, Janice Shaw, et al.
European Journal of Pharmacology
|
March 1, 2005
Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor
Donald R Gehlert, Anantha Shekhar, S Michelle Morin, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
January 25, 2008
Neuropeptide Y in the amygdala induces long-term resilience to stress-induced reductions in social responses but not hypothalamic-adrenal-pituitary axis activity or hyperthermia
Tammy J Sajdyk, Philip L Johnson, Randy J Leitermann, et al.
European Journal of Pharmacology
|
December 9, 2003
Na+-dependent high affinity binding of [3H]LY515300, a 3,4-dimethyl-4-(3-hydroxyphenyl)piperidine opioid receptor inverse agonist
Michael A Statnick, Todd M Suter, Susan L Gackenheimer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 15, 2002
Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder
Frank P Bymaster, Jason S Katner, David L Nelson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 9, 2007
3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethyl-imidazo[1,2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism
Donald R Gehlert, Andrea Cippitelli, Annika Thorsell, et al.
Page
of 5